Dolutegravir Sodium
1 NDC across 1 manufacturer|0 Generic,1 Brand
Dolutegravir Sodium is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 12, 2013. In 2024, Medicare Part D spent $629 million on Dolutegravir Sodium across 256,000 claims for 29,000 beneficiaries.
Dolutegravir Sodium is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $77.64 to $77.64 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$77.64 – $77.64
per EA
7d Activity
avg +0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ViiV Healthcare Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing DOLUTEGRAVIR SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TIVICAY 50 MG TABLET | $77.6356 per EA | +0.06% |
Frequently Asked Questions
What is Dolutegravir Sodium used to treat?
Dolutegravir Sodium is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Dolutegravir Sodium?
In 2024, Medicare Part D spent $629 million on Dolutegravir Sodium across 256,000 claims for 29,000 beneficiaries.
How many Dolutegravir Sodium products are on the market?
The Dolutegravir Sodium drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Dolutegravir Sodium?
NADAC reference prices for Dolutegravir Sodium range from $77.6356 to $77.6356 per EA.
Which manufacturers make Dolutegravir Sodium?
1 manufacturer lists Dolutegravir Sodium in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (1).
How has the price of Dolutegravir Sodium changed recently?
Over the past 7 days, 1 Dolutegravir Sodium NDC rose and 0 fell, with a market-wide average change of +0.1%.